These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neurochemical imaging in schizophrenia. Urban N; Abi-Dargham A Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402 [TBL] [Abstract][Full Text] [Related]
5. Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. Willeit M; Praschak-Rieder N Neuroimage; 2010 Nov; 53(3):878-92. PubMed ID: 20399868 [TBL] [Abstract][Full Text] [Related]
6. Brain radioligands--state of the art and new trends. Halldin C; Gulyás B; Langer O; Farde L Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163 [TBL] [Abstract][Full Text] [Related]
8. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights. Laruelle M; Huang Y Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162 [TBL] [Abstract][Full Text] [Related]
9. The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology. Malizia AL J Psychopharmacol; 2006 Jul; 20(4 Suppl):100-7. PubMed ID: 16785278 [TBL] [Abstract][Full Text] [Related]
10. Perfusion magnetic resonance imaging in psychiatry. Théberge J Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433 [TBL] [Abstract][Full Text] [Related]
11. Functional neuroimaging of hallucinations in schizophrenia: toward an integration of bottom-up and top-down approaches. Silbersweig D; Stern E Mol Psychiatry; 1996 Nov; 1(5):367-75. PubMed ID: 9154229 [TBL] [Abstract][Full Text] [Related]
12. Neuroimaging and the functional neuroanatomy of psychotherapy. Roffman JL; Marci CD; Glick DM; Dougherty DD; Rauch SL Psychol Med; 2005 Oct; 35(10):1385-98. PubMed ID: 16164763 [TBL] [Abstract][Full Text] [Related]
13. Neurobiological basis of depression: an update. Kalia M Metabolism; 2005 May; 54(5 Suppl 1):24-7. PubMed ID: 15877309 [TBL] [Abstract][Full Text] [Related]
15. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749 [TBL] [Abstract][Full Text] [Related]
16. [Psychopathology of schizophrenia and brain imaging]. Gross G; Huber G Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545 [TBL] [Abstract][Full Text] [Related]
17. An introduction to PET and SPECT neuroreceptor quantification models. Ichise M; Meyer JH; Yonekura Y J Nucl Med; 2001 May; 42(5):755-63. PubMed ID: 11337572 [TBL] [Abstract][Full Text] [Related]
19. [Strategy for development of imaging biomarkers]. Ishiwata K Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944 [TBL] [Abstract][Full Text] [Related]
20. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Hudson CJ; Young LT; Li PP; Warsh JJ Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]